140 related articles for article (PubMed ID: 33277667)
21. Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression.
Wu J; Liu X; Cai H; Wang Y
World J Surg Oncol; 2014 Feb; 12():40. PubMed ID: 24555747
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer.
Park JH; Ryu MH; Kim HJ; Ryoo BY; Yoo C; Park I; Park YS; Oh ST; Yook JH; Kim BS; Kang YK
Gastric Cancer; 2016 Jan; 19(1):226-33. PubMed ID: 25614467
[TBL] [Abstract][Full Text] [Related]
23. Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer.
Katsube T; Murayama M; Yamaguchi K; Usuda A; Shimazaki A; Asaka S; Konnno S; Miyaki A; Usui T; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Naritaka Y
Anticancer Res; 2015 May; 35(5):2969-74. PubMed ID: 25964583
[TBL] [Abstract][Full Text] [Related]
24. SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection.
Kim YM; Kwon IG; Choi SH; Noh SH; Chun J; Youn YH; Park H; Nahm JH; Kim JH; Huh YM; Jang E
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683460
[TBL] [Abstract][Full Text] [Related]
25. Bone recurrence after curative resection of gastric cancer.
Park JM; Song KY; O JH; Kim WC; Choi MG; Park CH
Gastric Cancer; 2013 Jul; 16(3):362-9. PubMed ID: 22961057
[TBL] [Abstract][Full Text] [Related]
26. Is timing of death from tumor recurrence predictable after curative resection for gastric cancer?
Otsuji E; Kobayashi S; Okamoto K; Hagiwara A; Yamagishi H
World J Surg; 2001 Nov; 25(11):1373-6. PubMed ID: 11760736
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients.
Zhao B; Huang X; Zhang J; Luo R; Lu H; Xu H; Huang B
Rev Esp Enferm Dig; 2019 Feb; 111(2):111-120. PubMed ID: 30404528
[TBL] [Abstract][Full Text] [Related]
28. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.
Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
[TBL] [Abstract][Full Text] [Related]
29. Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
Lee JW; Jo K; Cho A; Noh SH; Lee JD; Yun M
J Nucl Med; 2015 Oct; 56(10):1494-500. PubMed ID: 26251414
[TBL] [Abstract][Full Text] [Related]
30. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
[TBL] [Abstract][Full Text] [Related]
31. Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate.
Uña E
World J Surg Oncol; 2009 Sep; 7():69. PubMed ID: 19761613
[TBL] [Abstract][Full Text] [Related]
32. The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer.
Sawayama H; Iwatsuki M; Kuroda D; Toihata T; Uchihara T; Koga Y; Yagi T; Kiyozumi Y; Eto T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Baba H
Surg Today; 2018 Nov; 48(11):994-1003. PubMed ID: 29926189
[TBL] [Abstract][Full Text] [Related]
33. The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer.
Kim YJ; Chung WC; Youn GJ; Jun KH; Chin HM
Rev Esp Enferm Dig; 2019 Jul; 111(7):537-542. PubMed ID: 31215209
[TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy.
Xu J; Shen L; Shui Y; Yu W; Guo Q; Yu R; Wu Y; Wei Q
Cancer Med; 2020 Jul; 9(13):4724-4735. PubMed ID: 32420703
[TBL] [Abstract][Full Text] [Related]
35. The patterns and timing of recurrence after curative resection for gastric cancer in China.
Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
[TBL] [Abstract][Full Text] [Related]
36. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
37. Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer.
Sawaki K; Kanda M; Umeda S; Miwa T; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Anticancer Res; 2019 Nov; 39(11):6125-6133. PubMed ID: 31704840
[TBL] [Abstract][Full Text] [Related]
38. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
[TBL] [Abstract][Full Text] [Related]
39. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
40. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
